Bio-Reference Laboratories (BRLI) Tops Q3 EPS by 1c, Reaffirms FY; Company Also Acquires GeneDx
Tweet Send to a Friend
Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) reports Q3 EPS of $0.27, 1 cent better than estimates. Revenues were $49.03 million ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
